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Identity 
Hugo: AKAP9 
Other names: AKAP350; AKAP450; CG-NAP; 
HYPERION; KIAA0803; MU-RMS-40.16A; PRKA9; 
YOTIAO 
Location: 7q21.2 
DNA/RNA 
Description 
AKAP9 gene consists of 51 encoding exons with a total 
gene size of 169797 bp. 
Transcription 
The AKAP9 transcript has an open reading frame 
(ORF) of 11724 bp. Four different transcript variants 
have been identified (NM147171, NM005751, 
NM147185, NM147166). 
Protein 
Description 
The 11.7 kb ORF encodes for a 3908 aa protein with a 
predicted size of 453 kDa. Four different protein 
products have been described (NP005742.4, 
NP671695.1, NP671700.1, NP671714.1). 
Localisation 
Centrosomes, Golgi apparatus. 
Function 
AKAP9 belongs to the family of A-Kinase Anchor 
Proteins (AKAPs), which are scaffold proteins able to 
bind the type II regulatory subunit (RII) of cAMP 
dependent Protein Kinase A (PKA) and several other 
protein kinases and phosphatases and to anchor them to 
specific intracellular compartments. AKAP9 shows 
centrosome and Golgi compartmentalization. Various 
splice variants of the transcript are found in different 
human tissues. The AKAP9 protein contains the PKA 
binding domain, a large coiled-coil domain and C-
terminal centrosome binding domain. 
Implicated in 
Papillary Thyroid Carcinoma (PTC) 
Cytogenetics 
inv(7)(q21-22q34) with AKAP9-BRAF fusion. 
Breakpoints 
Note: Breakpoint in AKAP9-BRAF fusion is located 
within intron 8 of the gene. In this fusion, exons 1-8 of 
AKAP9 are fused with last 10 exons 9-18 of BRAF. In 
the fusion, AKAP9 lacks the centrosome binding 
domain and, as a result, the AKAP9-BRAF protein 
looses its cytoplasmic compartmentalization and 
appears to be diffusely distributed in the cytoplasm, as 
detected by immunofluorescence. 
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